- The trend backdrop is active with a 29-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
688253
SHH
Week ended 07 Aug 2026
Weekly Investor Report
Innovita Biological Technology Co., Ltd. · Healthcare · Biotechnology
Latest close
71.02 CNY
24.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 50.5% above the Trend Line and sits at 99.5% of its 52-week range. The latest completed week returned 24.3%, after a 31.7% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.
Setup score
69
out of 100
Latest Close
71.02 CNY
7 Aug 2026
1W Return
24.3%
latest completed week
4W Return
31.7%
short-term follow-through
12W Return
19.2%
quarterly tape
Trend Breadth
69.2%
36 of 52 weeks active
Volume Ratio
1.6x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- 6 reversal markers appear in the recent smart-money tape.
- Recent volatility is running well above the one-year baseline.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
24.3%
Latest completed week; four-week move 31.7%.
Indicator stack
83/37
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 50.5% above the Trend Line and sits at 99.5% of its 52-week range. The latest completed week returned 24.3%, after a 31.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8212-week average 0.90
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.82Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers66 reversal markers
No recent accumulation markers. 6 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 31.7% over four weeks, 19.2% over 12 weeks, and 119.3% over one year. The current trend has remained active for 29 consecutive weeks.
Performance by holding period
Active trend streak29 weeks
Active weeks in one year36
Trend breadth69.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.14Latest activity-pressure read.
Pressure change-128.3%Four-week change in activity pressure.
Leadership76.09Latest relative-leadership reading.
RS change98.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.3%Distance below the 52-week high.
13-week volatility11.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher16 of 2610 weeks finished lower.
Best week+24.3%Week of 7 Aug.
Worst week-16.7%Week of 29 May.
Latest week+24.3%Week of 7 Aug.
Shape of recent returns
Strong gains12
Modest gains4
Flat weeks0
Modest losses5
Sharp losses5
Recent vol11.2%13-week weekly-return volatility.
Base vol7.8%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew6.2% / -4.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank- / 100
Group average4.8%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD64.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCN Biotechnology
4-week rank3 / 100
Group average4.5%
Trend breadth15.0%
Trend15.0%active weekly trend signals
MD37.0%positive activity pressure
RS32.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape65/100
Trend, activity pressure, participation, and risk combine to a 65/100 tape read.
Indicator analysis75/100Latest 12-week confirmation: trend 12/12, activity pressure 9/12, relative leadership 12/12.
Activity pressure 0.82; 6 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Price to sales forward of Innovita Biological Technology Co., Ltd. Class A – SSE:688253 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 71.02 CNY | 24.3% | 47.18 CNY | 35.05 CNY | -0.14 | 76.09 | 13.7M | On |
| 31 Jul 2026 | 57.15 CNY | 4.4% | 45.82 CNY | 34.74 CNY | -0.27 | 48.17 | 9.3M | On |
| 24 Jul 2026 | 54.75 CNY | 9.5% | 44.94 CNY | 34.52 CNY | -0.01 | 44.21 | 10.2M | On |
| 17 Jul 2026 | 50.01 CNY | -7.3% | 44.17 CNY | 34.32 CNY | 0.18 | 34.89 | 9.6M | On |
| 10 Jul 2026 | 53.93 CNY | -14.2% | 43.54 CNY | 34.15 CNY | 0.49 | 38.26 | 8.2M | On |
| 3 Jul 2026 | 62.85 CNY | 8.4% | 42.84 CNY | 33.95 CNY | 0.63 | 60.77 | 1.4M | On |
| 26 Jun 2026 | 58.00 CNY | -1.2% | 41.90 CNY | 33.70 CNY | 0.62 | 50.95 | 2.4M | On |
| 19 Jun 2026 | 58.70 CNY | 2.3% | 40.98 CNY | 33.48 CNY | 0.81 | 52.11 | 9.2M | On |
| 12 Jun 2026 | 57.37 CNY | 0.3% | 40.19 CNY | 33.27 CNY | 1.01 | 52.51 | 2.0M | On |
| 5 Jun 2026 | 57.17 CNY | 5.6% | 39.43 CNY | 33.06 CNY | 1.28 | 53.61 | 1.7M | On |
| 29 May 2026 | 54.15 CNY | -16.7% | 38.58 CNY | 32.85 CNY | 1.46 | 45.44 | 14.8M | On |
| 22 May 2026 | 65.01 CNY | 9.1% | 37.83 CNY | 32.65 CNY | 1.59 | 74.01 | 13.8M | On |
| 15 May 2026 | 59.59 CNY | 18.5% | 36.67 CNY | 32.39 CNY | 1.60 | 60.82 | 16.4M | On |
| 8 May 2026 | 50.28 CNY | -2.7% | 35.71 CNY | 32.17 CNY | 1.58 | 35.73 | 7.9M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.